Overview
Digitoxigenin is a pharmacologically active cardenolide derived from Digitalis plants, notably Digitalis purpurea and Digitalis lanata. As the aglycone moiety of digitoxin and related cardiac glycosides, it represents the biologically active core structure responsible for these compounds' therapeutic effects. The compound was first isolated in the early 20th century during studies of foxglove's medicinal properties. In modern applications, digitoxigenin serves as a crucial intermediate for synthesizing cardiac medications and as a research tool in cardiovascular physiology studies. Its mechanism of action involves specific inhibition of myocardial Na+/K+-ATPase, leading to increased intracellular calcium concentrations and enhanced cardiac contractility.
Physical and Chemical Properties
Digitoxigenin crystallizes as a white powder with characteristic steroid-like properties. The molecule contains a cis-fused A/B ring system (5β configuration) and an α,β-unsaturated γ-lactone ring at C17, essential for biological activity. It demonstrates moderate stability under normal conditions but degrades upon prolonged exposure to light or extreme pH. The compound's hydroxyl groups at C3 (β-configuration) and C14 contribute to its polarity and hydrogen-bonding capacity. Its solubility profile shows preferential dissolution in polar organic solvents over water, with logP values indicating moderate lipophilicity. Spectroscopic characteristics include UV absorption maxima at 220 nm due to the lactone moiety.
Main Applications
Pharmaceutical manufacturing constitutes digitoxigenin's primary industrial application, where it serves as a precursor for cardiac glycosides like digitoxin and digoxin. These medications treat congestive heart failure and certain arrhythmias through positive inotropic effects. The compound's stereospecific structure makes it valuable for structure-activity relationship studies in drug development. In research settings, digitoxigenin is employed as a specific Na+/K+-ATPase inhibitor to study ion transport mechanisms and cardiac cell signaling. Recent investigations explore its potential anticancer properties through modulation of cell signaling pathways, though these applications remain experimental.
Safety and Storage
As a potent cardiotonic agent, digitoxigenin requires careful handling with appropriate personal protective equipment (PPE), including gloves and eye protection. Inhalation of dust and skin contact must be avoided due to rapid systemic absorption and narrow therapeutic index. Workplace exposure limits should follow strict pharmaceutical compound guidelines. Proper storage involves amber glass containers under inert atmosphere at controlled refrigeration temperatures (2-8°C). Stability studies indicate decomposition above 40°C or under prolonged light exposure. Laboratories should maintain spill kits with absorbent materials for powdered form, and waste disposal must comply with hazardous pharmaceutical waste regulations.
B2B Procurement Guide
Pharmaceutical-grade digitoxigenin typically requires certification of analysis including HPLC purity (>98%), residual solvent content, and microbial limits. Bulk purchases for manufacturing often involve long-term contracts with Digitalis extract suppliers or specialized fine chemical producers. Current market trends show increasing demand for semi-synthetic production via bioconversion methods. Buyers should verify compliance with regional pharmaceutical regulations (e.g., FDA DMF filings, EU CEP). For research quantities, reputable biochemical suppliers offer small-scale quantities with full spectroscopic characterization. Lead times for custom synthesis can extend to 8-12 weeks. Import/export may require special permits due to controlled substance classifications in some jurisdictions.
Related Manufacturers
- 主营：中药标准品、标准品对照品、天然化合物、毛地黄制剂、标准品、分析试剂、细胞实验、动物实验、中药提取物、单体化合物、科研实验用